Early multidrug regimens in new potentially fatal medical problems
Rev Cardiovasc Med
.
2020 Dec 30;21(4):507-508.
doi: 10.31083/j.rcm.2020.04.270.
Authors
Peter A McCullough
1
2
3
,
Ramin Oskoui
4
Affiliations
1
Baylor University Medical Center, Dallas, 75226, TX, USA.
2
Baylor Heart and Vascular Institute, Dallas, 75226, TX, USA.
3
Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, 75226, TX, USA.
4
Foxhall Cardiology, Washington, 20016, DC, USA.
PMID:
33387995
DOI:
10.31083/j.rcm.2020.04.270
No abstract available
MeSH terms
COVID-19 / mortality
COVID-19 Drug Treatment*
Drug Therapy, Combination
Humans
Treatment Outcome